319 related articles for article (PubMed ID: 25194444)
21. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
22. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
[TBL] [Abstract][Full Text] [Related]
23. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
[TBL] [Abstract][Full Text] [Related]
24. POT1 as a terminal transducer of TRF1 telomere length control.
Loayza D; De Lange T
Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
[TBL] [Abstract][Full Text] [Related]
25. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection.
Lei M; Podell ER; Cech TR
Nat Struct Mol Biol; 2004 Dec; 11(12):1223-9. PubMed ID: 15558049
[TBL] [Abstract][Full Text] [Related]
26. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
[TBL] [Abstract][Full Text] [Related]
27. Control of telomere length by the human telomeric protein TRF1.
van Steensel B; de Lange T
Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
[TBL] [Abstract][Full Text] [Related]
28. Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability.
Bunch JT; Bae NS; Leonardi J; Baumann P
Mol Cell Biol; 2005 Jul; 25(13):5567-78. PubMed ID: 15964812
[TBL] [Abstract][Full Text] [Related]
29. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
[TBL] [Abstract][Full Text] [Related]
30. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
[TBL] [Abstract][Full Text] [Related]
31. Telomerase activity in human renal cell carcinoma.
Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
[TBL] [Abstract][Full Text] [Related]
32. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma.
Kondo T; Oue N; Yoshida K; Mitani Y; Naka K; Nakayama H; Yasui W
Cancer Res; 2004 Jan; 64(2):523-9. PubMed ID: 14744765
[TBL] [Abstract][Full Text] [Related]
33. The spatiotemporal expression of TERT and telomere repeat binding proteins in the postnatal mouse testes.
Kosebent EG; Ozturk S
Andrologia; 2021 Apr; 53(3):e13976. PubMed ID: 33544428
[TBL] [Abstract][Full Text] [Related]
34. PTOP interacts with POT1 and regulates its localization to telomeres.
Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
[TBL] [Abstract][Full Text] [Related]
35. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
[TBL] [Abstract][Full Text] [Related]
36. Protection against chromosome degradation at the telomeres.
Grandin N; Charbonneau M
Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802
[TBL] [Abstract][Full Text] [Related]
37. Regulation of telomerase by telomeric proteins.
Smogorzewska A; de Lange T
Annu Rev Biochem; 2004; 73():177-208. PubMed ID: 15189140
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
Bitisik O; Yavuz S; Yasasever V; Dalay N
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367
[TBL] [Abstract][Full Text] [Related]
39. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Abe N; Watanabe T; Nakashima M; Masaki T; Mori T; Sugiyama M; Atomi Y
Hepatogastroenterology; 2001; 48(39):692-5. PubMed ID: 11462905
[TBL] [Abstract][Full Text] [Related]
40. Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol.
Liu Y; Wu BQ; Zhong HH; Xu ML; Fang WG
Pathol Int; 2010 May; 60(5):386-94. PubMed ID: 20518889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
